Search
for

    Sort by

    Research 661–690 of 1000+

    1. Cutaneous Lupus Erythematosus Springer eBooks · 2017
    2. Drug Discovery Today: Therapeutic Strategies - 2006 Editorial Drug Discovery Today: Therapeutic Strategies · 2006
    3. Pre-aggregation of scalp progenitor dermal and epidermal stem cells activates the WNT pathway and promotes hair follicle formation in in vitro and in vivo systems Stem Cell Research & Therapy · 2019 · 17 citations
    4. Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma Archives of Medical Science · 2017 · 16 citations
    5. Circ 0020938 inhibits hair follicle stem cells proliferation via the miR-142-5p/DSG4 axis in cashmere goats BMC Genomics · 2025
    6. Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know? Reviews in Endocrine and Metabolic Disorders · 2015 · 111 citations
    7. Predominant expression of 5 alpha-reductase type 1 in pubic skin from normal subjects and hirsute patients. 1996 · 11 citations
    8. Chapter 23. Therapeutic Control of Androgen Action Annual Reports in Medicinal Chemistry · 1994 · 7 citations
    9. Comparison of Clinical Efficacy of Finasteride and Dutasteride as 5-alpha Reductase Inhibitor Daehan namseong gwahag hoeji · 2012 · 1 citations
    10. Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies Biomedicines · 2025
    11. Bioprospecting of Potential Inhibitors of 5alpha Reductase 2 Inhibitors from Relevant Ethno-pharmacological Plants via In Silico Techniques Scientific African · 2024
    12. Symptoms of hypogonadism caused by 5α-reductase inhibitors International journal of family & community medicine · 2017
    13. ChemInform Abstract: Rα‐Reductase Inhibitors‐ — The Finasteride Story ChemInform · 2011
    14. Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis Galen Medical Journal · 2025
    15. An overview on 5α-reductase inhibitors Steroids · 2009 · 219 citations
    16. Neurosteroids, neuroactive steroids, and symptoms of affective disorders Pharmacology, Biochemistry and Behavior · 2006 · 82 citations
    17. Effect of finasteride on the ovulatory function of normal women Fertility and Sterility · 2003 · 4 citations
    18. Isolation and HPLC Quantitative Determination of 5α-Reductase Inhibitors from Tectona grandis L.f. Leaf Extract Molecules · 2022
    19. First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors Journal of clinical oncology · 2011 · 505 citations
    20. Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human Endocrinology · 1985 · 193 citations
    21. The PDGF/PDGFR pathway as a drug target Molecular Aspects of Medicine · 2017 · 182 citations
    22. A Hot New Twist to Hair Biology ˜The œAmerican journal of pathology (Print) · 2005 · 174 citations
    23. Targeting the Wnt pathways for therapies Molecular and cellular therapies · 2014 · 112 citations
    24. 9 Role of 5α-reductase in health and disease Baillière's clinical endocrinology and metabolism · 1994 · 101 citations
    25. Endocrine control of benign prostatic hyperplasia Andrology · 2016 · 97 citations
    26. The roles of Wnt/β‐catenin pathway in tissue development and regenerative medicine Journal of Cellular Physiology · 2017 · 89 citations
    27. Ritlecitinib: First Approval Drugs · 2023 · 84 citations
    28. The role of lymphocytes in the development and treatment of alopecia areata Expert Review of Clinical Immunology · 2015 · 60 citations
    29. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications The Prostate · 1986 · 57 citations
    30. Actions of 5α-reductase inhibitors on the epididymis Molecular and Cellular Endocrinology · 2006 · 48 citations